Integrated Filing — IndAS
General information about company
| Scrip Code |
530549 |
| NSE Symbol |
SHILPAMED |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE790G01031 |
| Name of company |
SHILPA MEDICARE LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
13-11-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
05-11-2025 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Second quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Single segment |
| Description of single segment |
PHARMACETICAL |
| Start date and time of board meeting |
13-11-2025 12:20:00 |
| End date and time of board meeting |
13-11-2025 14:20:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Not applicable |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
36,996.88 |
69,142.62 |
|
Other income |
175.44 |
813.32 |
|
Total income |
37,172.32 |
69,955.94 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
12,763.53 |
24,268.02 |
| (b) |
Purchases of stock-in-trade |
735.76 |
1,151.26 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(2,949.58) |
(6,908.97) |
| (d) |
Employee benefit expense |
8,305.21 |
16,486.61 |
| (e) |
Finance costs |
1,566.80 |
3,444.92 |
| (f) |
Depreciation, depletion and amortisation expense
|
2,982.28 |
5,874.31 |
| (f) |
Other Expenses |
| 1 |
Other Expenses |
7,313.93 |
14,154.09 |
|
Total other expenses |
7,313.93 |
14,154.09 |
|
Total expenses |
30,717.93 |
58,470.24 |
| 3 |
Total profit before exceptional items and tax |
6,454.39 |
11,485.70 |
| 4 |
Exceptional items |
0.00 |
0.00 |
| 5 |
Total profit before tax |
6,454.39 |
11,485.70 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
2,129.34 |
2,881.06 |
| 8 |
Deferred tax |
(93.04) |
(575.32) |
| 9 |
Total tax expenses |
2,036.30 |
2,305.74 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
4,418.09 |
9,179.96 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
(11.41) |
(84.70) |
| 16 |
Total profit (loss) for period |
4,406.68 |
9,095.26 |
| 17 |
Other comprehensive income net of taxes |
(3.56) |
(7.12) |
| 18 |
Total Comprehensive Income for the period |
4,403.12 |
9,088.14 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
|
|
|
Total profit or loss, attributable to non-controlling interests |
|
|
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
|
|
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
|
|
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
977.91 |
977.91 |
|
Face value of equity share capital |
1 |
1 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
2.25 |
4.65 |
|
Diluted earnings (loss) per share from continuing operations |
2.25 |
4.65 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
2.25 |
4.65 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
2.25 |
4.65 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
30-09-2025 |
| Whether results are audited or unaudited |
Unaudited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
1,16,491.01 |
|
Capital work-in-progress |
53,372.91 |
|
Investment property |
|
|
Goodwill |
4,623.08 |
|
Other intangible assets |
20,309.72 |
|
Intangible assets under development |
38,637.15 |
|
Biological assets other than bearer plants |
|
|
Investments accounted for using equity method |
|
|
Non-current financial assets |
|
|
Non-current investments |
3,239.49 |
|
Trade receivables, non-current |
|
|
Loans, non-current |
0.00 |
|
Other non-current financial assets |
630.30 |
|
Total non-current financial assets |
3,869.79 |
|
Deferred tax assets (net) |
2,770.04 |
|
Other non-current assets |
3,559.37 |
|
Total non-current assets |
2,43,633.07 |
| 2 |
Current assets |
|
|
Inventories |
44,486.86 |
|
Current financial asset |
|
|
Current investments |
0.00 |
|
Trade receivables, current |
42,688.11 |
|
Cash and cash equivalents |
1,795.25 |
|
Bank balance other than cash and cash equivalents |
401.46 |
|
Loans, current |
0.00 |
|
Other current financial assets |
3,158.29 |
|
Total current financial assets |
48,043.11 |
|
Current tax assets (net) |
|
|
Other current assets |
11,442.21 |
|
Total current assets |
1,03,972.18 |
| 3 |
Non-current assets classified as held for sale |
1,905.60 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
|
|
Total assets |
3,49,510.85 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
977.91 |
|
Other equity |
2,42,741.94 |
|
Total equity attributable to owners of parent |
2,43,719.85 |
|
Non controlling interest |
132.21 |
|
Total equity |
2,43,852.06 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
18,958.90 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
5,909.03 |
|
Total non-current financial liabilities |
24,867.93 |
|
Provisions, non-current |
2,757.77 |
|
Deferred tax liabilities (net) |
0.00 |
|
Deferred government grants, Non-current |
0.00 |
|
Other non-current liabilities |
0.00 |
|
Total non-current liabilities |
27,625.70 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
40,166.67 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
1,526.76 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
14,975.27 |
|
Total Trade payable |
16,502.03 |
|
Other current financial liabilities |
14,089.75 |
|
Total current financial liabilities |
70,758.45 |
|
Other current liabilities |
3,162.02 |
|
Provisions, current |
3,070.87 |
|
Current tax liabilities (Net) |
1,041.75 |
|
Deferred government grants, Current |
0.00 |
|
Total current liabilities |
78,033.09 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
|
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
|
|
Total liabilities |
1,05,658.79 |
|
Total equity and liabilites |
3,49,510.85 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| Date of end of reporting
period |
30-09-2025 |
30-09-2025 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
|
Total Segment Revenue |
|
|
|
Less: Inter segment revenue |
|
|
|
Revenue from operations |
|
|
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
|
Total Profit before tax |
|
|
|
i. Finance cost |
|
|
|
ii. Other Unallocable Expenditure net off Unallocable income |
|
|
|
Profit before tax |
|
|
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
|
Total Segment Asset |
|
|
|
Un-allocable Assets |
null |
null |
|
Net Segment Asset |
null |
null |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
|
Total Segment Liabilities |
|
|
|
Un-allocable Liabilities |
null |
null |
|
Net Segment Liabilities |
null |
null |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Remeasurement of the defined benefit (liability)/asset |
-481000 |
-962000 |
| 2 |
Income tax relating to the above |
125000 |
250000 |
|
Total Amount of items that will not be reclassified to profit and loss |
(3.56) |
(7.12) |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
0.00 |
0.00 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
|
Total Amount of items that will be reclassified to profit and loss |
|
|
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
(3.56) |
(7.12) |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
30-09-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
11,485.70 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
2,501.87 |
|
Adjustments for decrease (increase) in inventories |
(10,471.85) |
|
Adjustments for decrease (increase) in trade receivables, current |
1,962.61 |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
0.00 |
|
Adjustments for decrease (increase) in other non-current assets |
2,118.23 |
|
Adjustments for other financial assets, non-current |
0.00 |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
6,845.95 |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
0.00 |
|
Adjustments for increase (decrease) in other non-current liabilities
|
1,484.41 |
|
Adjustments for depreciation and amortisation expense |
5,874.32 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
0.00 |
|
Adjustments for provisions, current |
0.00 |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
0.00 |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
(1,604.09) |
|
Adjustments for dividend income |
0.00 |
|
Adjustments for interest income |
22.50 |
|
Adjustments for share-based payments |
0.00 |
|
Adjustments for fair value losses (gains) |
943.05 |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
0.00 |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
1,267.18 |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
10,899.18 |
|
Net cash flows from (used in)
operations |
22,384.88 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
2,266.77 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
20,118.11 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
1,775.85 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
0.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
0.00 |
|
Purchase of property, plant and equipment |
16,271.35 |
|
Proceeds from sales of investment property |
957.98 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
0.00 |
|
Interest received |
25.88 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
investing activities |
(17,063.34) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
0.00 |
|
Proceeds from issuing other equity instruments |
0.00 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
489.31 |
|
Repayments of borrowings |
0.00 |
|
Payments of lease liabilities |
34.03 |
|
Dividends paid |
977.91 |
|
Interest paid |
2,499.41 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
financing activities |
(3,022.04) |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
32.73 |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
(692.99) |
|
Net increase (decrease) in cash
and cash equivalents |
(660.26) |
|
Cash and cash equivalents cash flow statement at beginning of period
|
2,856.98 |
|
Cash and cash equivalents cash
flow statement at end of period |
2,196.72 |